コンテンツぞスキップ
Merck

539164

Proteasome Inhibitor Set I

proteasome inhibitor, solid

ログむンで組織・契玄䟡栌をご芧ください。

サむズを遞択しおください

衚瀺を倉曎する

この商品に぀いお

UNSPSC Code:
12352200
NACRES:
NA.77
eCl@ss:
32150313
Form:
solid
Storage condition:
OK to freeze
テクニカルサヌビス
お困りのこずがあれば、経隓豊富なテクニカルサヌビスチヌムがお客様をサポヌトしたす。
お手䌝いしたす


補品名

Proteasome Inhibitor Set I, The Proteasome Inhibitor Set I controls the biological activity of Proteasome. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Quality Segment

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

shipped in

ambient

storage temp.

−20°C

General description

Proteasomes are large multi-subunit protease complexes, localized in the nucleus and cytosol, which selectively degrade intracellular proteins. They play a major role in the degradation of many proteins involved in cell cycling, proliferation, and apoptosis. A vast majority of short-lived proteins are degraded by the ubiquitin-proteasome pathway. A protein marked for degradation is covalently attached to multiple molecules of ubiquitin (Ubq), a highly conserved 76-amino acid (8.6 kDa) protein, which escorts it for rapid hydrolysis to the multi-component enzymatic complex known as the 26S proteasome. The proteolytic core of this complex, the 20S proteasome, contains multiple peptidase activities and functions as the catalytic machine.



The ubiquitin-proteasome pathway plays a major role in the breakdown of abnormal proteins that result from oxidative stress and mutations that might otherwise disrupt normal cellular homeostasis. The reactive oxygen species can promote partial unfolding of the proteins, exposing its hydrophobic domains to proteolytic enzymes of the 20S complex. Rapid degradation of defective enzymes, as seen in diseases caused by metabolic abnormalities, also occurs in the proteasome. The Ubq-proteasome pathway has also been implicated in several forms of malignancy, in the pathogenesis of several genetic diseases, and in the pathology of muscle wasting. It is also involved in the destruction of proteins that participate in cell cycle progression, transcription control, signal transduction, and metabolic regulation.

Biochem/physiol Actions

Primary Target
MPC
Secondary Target
NF-κB activity

Other Notes

Grimm, L.M., et al. 1996. EMBO J.15, 3835.
Griscavage, J.M., et al. 1996. Proc. Natl. Acad. Sci. USA93, 3308.
Lee, D.H., and Goldberg, A.L. 1996. J. Biol. Chem.271, 27280.
Oda, K., et al. 1996. Biochem. Biophys. Res. Commun.219, 800.
Fenteany, G., et al. 1995. Science268, 726.
Traenckner, E.B., et al. 1994. EMBO J.13, 5433.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)


保管分類

11 - Combustible Solids


適甚法什

詊隓研究甚途を考慮した関連法什を䞻に挙げおおりたす。化孊物質以倖に぀いおは、䞀郚の情報のみ提䟛しおいたす。 補品を安党か぀合法的に䜿甚するこずは、䜿甚者の矩務です。最新情報により修正される堎合がありたす。WEBの反映には時間を芁するこずがあるため、適宜SDSをご参照ください。

キットコンポヌネントの情報を参照しおください

jan

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart



最新バヌゞョンのいずれかを遞択しおください

詊隓成瞟曞COA

Lot/Batch Number

適切なバヌゞョンが芋぀かりたせんか。

特定のバヌゞョンが必芁な堎合は、ロット番号たたはバッチ番号で特定の蚌明曞を怜玢できたす。

以前この補品を賌入いただいたこずがある堎合

文曞ラむブラリで、最近賌入した補品の文曞を怜玢できたす。

文曞ラむブラリにアクセスする